Drugdiscovery >> Drug Development >> News
2583
Views
Cytokinetics failed FDA's approval - drugdiscovery.com
Cytokinetics failed FDA's approval - drugdiscovery.com


Cytokinetics' new ASÉ drug has failed clinical trials and was not approved by FDA. The drug has not reached the efficiency endpoint, therefore further research is going to be needed.
Read More >>


Tags: drug, drug discovery, ASL drug, Cytokinetics asl drug, FDA approval, FDA approval of asl drugs. - April 29, 2014
Related Articles
4522
Views
Stem cells in a clinical trial for the treatment of MS Stem cells in a clinical trial for the treatment of MS
FDA has approved autologous, mesenchymal stem cell-derived neural progenitor cells (MSC-NPs) as an Investigational New Drug (IND) for a phase 1 clinical trial in the treatment of multiple sclerosis. Read More >>

Tags: stemm cells, mesenhymal, multiple sclerosis, FDA approval, clinical trial,investigational new drug

3171
Views
Anika's Joint Mobility Drug has gained FDA Approval Anika's Joint Mobility Drug has gained FDA Approval
Monovisc, a single injection which is used for treating pain and increasing joint mobility has gained FDA Marketing approval. The drug is non-animal based and uses , viscoelastic fluid composed of par Read More >>

Tags: Drug, Anika, Anika therapeutics, joint, pain, joint mobility, single injection

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013